A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis

NCT06238817 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

241

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Ruxolitinib Cream
DRUG: Vehicle Cream

Sponsor

Incyte Corporation